ESR1 and breast carcinoma: PFKFB3 is a direct target of E2 action; in ER-responsive breast cancer cells (MCF-7), E2 promotes PFKFB3 mRNA transcription and up-regulates PFKFB3 protein expression through ERα via direct binding to PFKFB3 promoter [79].